Table 6.
Top 10 most cited authors related to lung cancer immunotherapy from 2010 to 2022.
| Name | Paper number | Total citation | H-index | Average citations per paper | Articles fractionalized a | Top paper number | Top paper rate | First publication year |
|---|---|---|---|---|---|---|---|---|
| Reck M | 44 | 22380 | 29 | 508.64 | 4.52 | 17 | 38.64% | 2012 |
| Hellmann MD | 35 | 18839 | 32 | 538.26 | 2.38 | 17 | 48.57% | 2015 |
| Paz-Ares L | 25 | 18588 | 19 | 743.52 | 1.88 | 11 | 44.00% | 2015 |
| Horn L | 25 | 17583 | 24 | 703.32 | 1.66 | 13 | 52.00% | 2015 |
| Garon EB | 22 | 17190 | 19 | 781.36 | 1.8 | 8 | 36.36% | 2015 |
| Lubiniecki GM | 6 | 15257 | 6 | 2542.83 | 0.34 | 5 | 83.33% | 2015 |
| Brahmer JR | 21 | 15116 | 19 | 719.81 | 1.91 | 6 | 28.57% | 2013 |
| Felip E | 24 | 13763 | 21 | 573.46 | 1.27 | 10 | 41.67% | 2015 |
| Rizvi NA | 17 | 13704 | 16 | 806.12 | 1.42 | 12 | 70.59% | 2015 |
| Spigel DR | 17 | 12660 | 15 | 744.71 | 1.31 | 7 | 41.18% | 2015 |
a
Articles Fractionalized = paper number/total number of authors of the papers.